Cargando…

COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo

Identification of novel anti-cancer compounds with high efficacy and low toxicity is critical in drug development. High-throughput screening and other such strategies are generally resource-intensive. Therefore, in silico computer-aided drug design has gained rapid acceptance and popularity. We empl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salim, Kowthar Y., Vareki, Saman Maleki, Danter, Wayne R., Koropatnick, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173065/ https://www.ncbi.nlm.nih.gov/pubmed/27150056 http://dx.doi.org/10.18632/oncotarget.9133

Ejemplares similares

Correction: COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo
por: Salim, Kowthar Y., et al.
Publicado: (2017)

Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines
por: Maleki Vareki, Saman, et al.
Publicado: (2018)

Inhibition of BRCA2 and Thymidylate Synthase Creates Multidrug Sensitive Tumor Cells via the Induction of Combined “Complementary Lethality”
por: Rytelewski, Mateusz, et al.
Publicado: (2013)

The Effect of the Gut Microbiota on Systemic and Anti-Tumor Immunity and Response to Systemic Therapy against Cancer
por: Aghamajidi, Azin, et al.
Publicado: (2022)

Thiosemicarbazone Derivatives Developed to Overcome COTI-2 Resistance
por: Pósa, Vivien, et al.
Publicado: (2022)

High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
por: Maleki Vareki, Saman
Publicado: (2018)

Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy
por: Gameiro, Steven F., et al.
Publicado: (2018)

Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, gamma radiation, and cisplatin
por: Vareki, Saman Maleki, et al.
Publicado: (2014)

siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabine
por: Di Cresce, Christine, et al.
Publicado: (2015)

Addressing the Elephant in the Immunotherapy Room: Effector T-Cell Priming versus Depletion of Regulatory T-Cells by Anti-CTLA-4 Therapy
por: Hong, Megan M Y, et al.
Publicado: (2022)

Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy
por: Krishnamoorthy, Mithunah, et al.
Publicado: (2021)

The role of gut microbiome in immune modulation in metastatic renal cell carcinoma
por: Deluce, Jasna, et al.
Publicado: (2022)

Localization of the CotY and ExsY proteins to the exosporium basal layer of Bacillus anthracis
por: Durand‐Heredia, Jorge, et al.
Publicado: (2022)

IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer Cells
por: Maleki Vareki, Saman, et al.
Publicado: (2015)

Neoadjuvant Immunotherapy for High-Risk, Resectable Malignancies: Scientific Rationale and Clinical Challenges
por: Krishnamoorthy, Mithunah, et al.
Publicado: (2021)

Degradation of MYC by the mutant p53 reactivator drug, COTI-2 in breast cancer cells
por: Tang, Minhong, et al.
Publicado: (2023)

Mechanochemical Synthesis and Nitrogenation of the Nd(1.1)Fe(10)CoTi Alloy for Permanent Magnet
por: Martínez Sánchez, Hugo, et al.
Publicado: (2021)

TdIF1-LSD1 Axis Regulates Epithelial—Mesenchymal Transition and Metastasis via Histone Demethylation of E-Cadherin Promoter in Lung Cancer
por: Liu, Qi, et al.
Publicado: (2021)

COTI-2 induces cell apoptosis in pediatric acute lymphoblastic leukemia via upregulation of miR-203
por: Guo, Yingmeng, et al.
Publicado: (2020)

SAT-417 Personalized Treatment Planning for Radioiodine Therapy of Graves’ Disease;The Collar Therapy Indicator(CoTI)
por: Santhanam, Prasanna, et al.
Publicado: (2020)

Immunomodulation in Pancreatic Cancer
por: Krishnamoorthy, Mithunah, et al.
Publicado: (2020)

The Role of Microbiota-Derived Vitamins in Immune Homeostasis and Enhancing Cancer Immunotherapy
por: Gholami, Hasti, et al.
Publicado: (2023)

In Vitro and In Vivo Activity of a Novel Antifungal Small Molecule against Candida Infections
por: Wong, Sarah Sze Wah, et al.
Publicado: (2014)

Bifunctional Small Molecules Enhance Neutrophil Activities Against Aspergillus fumigatus in vivo and in vitro
por: Jones, Caroline N., et al.
Publicado: (2019)

The Morphogenetic Protein CotE Positions Exosporium Proteins CotY and ExsY during Sporulation of Bacillus cereus
por: Lablaine, Armand, et al.
Publicado: (2021)

A novel selective small-molecule PI3K inhibitor is effective against human multiple myeloma in vitro and in vivo
por: Glauer, J, et al.
Publicado: (2013)

Reciprocal positive selection for weakness - preventing olaparib resistance by inhibiting BRCA2
por: Rytelewski, Mateusz, et al.
Publicado: (2016)

Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 Is Based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated Efflux
por: Bormio Nunes, Julia H., et al.
Publicado: (2020)

HPV-Positive and -Negative Cervical Cancers Are Immunologically Distinct
por: Evans, Andris M., et al.
Publicado: (2022)

Emerging Biomarker-Guided Therapies in Prostate Cancer
por: Deluce, Jasna E., et al.
Publicado: (2022)

Moving on from Metchnikoff: thinking about microbiome therapeutics in cancer
por: Vareki, Saman Maleki, et al.
Publicado: (2018)

DeepNEU: cellular reprogramming comes of age – a machine learning platform with application to rare diseases research
por: Danter, Wayne R.
Publicado: (2019)

Therapeutic Targeting of P53: A Comparative Analysis of APR-246 and COTI-2 in Human Tumor Primary Culture 3-D Explants
por: Nagourney, Adam J., et al.
Publicado: (2023)

The effects of bare metal versus drug-eluting stent implantation on circulating endothelial cells following percutaneous coronary intervention(*)
por: Jazi, Seyed Mohammad Hashemi, et al.
Publicado: (2011)

Small molecules of herbal origin for osteoarthritis treatment: in vitro and in vivo evidence
por: Zhang, Penghui, et al.
Publicado: (2022)

Adenylosuccinic Acid Is a Non-Toxic Small Molecule In Vitro and In Vivo
por: Timpani, Cara A., et al.
Publicado: (2023)

Viral pandemic preparedness: A pluripotent stem cell‐based machine‐learning platform for simulating SARS‐CoV‐2 infection to enable drug discovery and repurposing
por: Esmail, Sally, et al.
Publicado: (2020)

Glial activation positron emission tomography imaging in radiation treatment of breast cancer brain metastases
por: Badiuk, Sawyer Rhae, et al.
Publicado: (2022)

DeepNEU: Artificially Induced Stem Cell (aiPSC) and Differentiated Skeletal Muscle Cell (aiSkMC) Simulations of Infantile Onset POMPE Disease (IOPD) for Potential Biomarker Identification and Drug Discovery
por: Esmail, Sally, et al.
Publicado: (2019)

Lung organoid simulations for modelling and predicting the effect of mutations on SARS-CoV-2 infectivity
por: Esmail, Sally, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ij9hllqbknqe0gr2os65ic933p